PLUS1
0.1725
0.00125 (0.73%)
0.00125 (0.73%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cannibics Pharmaceuticals Inc (QB) | CNBX | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00125 | 0.73% | 0.1725 | 0.14255 | 0.1725 | 0.14255 | 0.17125 | 16:30:15 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.1293 | 0.1725 | 0.0432 | 25.04% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 68 | 120,409 | $ 0.169147 | $ 20,367 | 642,251 | 0.066 - 0.61 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:56:01 | 1,100 | $ 0.1725 | USD |
Cannibics Pharmaceuticals (QB) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 23.29M | 135.04M | $ -3.78M | - | - | 45.32M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 667.21k | $ - | 0.00% | - | - |
Cannibics Pharmaceuticals (QB) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/29/2019 | 09:05 | Edgar (US Regulatory) | Annual Report (10-k) |
| 11/08/2019 | 06:05 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/07/2019 | 17:14 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/11/2019 | 16:11 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/07/2019 | 10:00 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/03/2019 | 13:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 7/23/2019 | 13:46 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNBX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.17 | 0.18 | 0.12 | 0.1610016 | 285,917 | 0.0025 | 1.47% |
| 1 Month | 0.2803 | 0.395 | 0.12 | 0.2046004 | 420,433 | -0.1078 | -38.46% |
| 3 Months | 0.299 | 0.61 | 0.12 | 0.3579147 | 571,660 | -0.1265 | -42.31% |
| 6 Months | 0.20295 | 0.61 | 0.066 | 0.2921181 | 442,548 | -0.03045 | -15.0% |
| 1 Year | 0.37 | 0.61 | 0.066 | 0.2923474 | 263,081 | -0.1975 | -53.38% |
| 3 Years | 2.765 | 2.99 | 0.066 | 0.9290346 | 315,334 | -2.59 | -93.76% |
| 5 Years | 0.2698 | 7.60 | 0.021 | 1.34 | 317,418 | -0.0973 | -36.06% |
Cannibics Pharmaceuticals (QB) Description
| Cannabics Pharmaceuticals Inc. (CNBX), is dedicated to the development of personalized diagnostic tools to provide supportive data for practitioners and patients regarding cannabinoid based cancer therapy. The Company's R&D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and current medical clinical studies which are registered with the US NIH. Cannabics is now creating tailored therapies for cancer patients, utilizing advanced Liquid Biopsy and HTS technology along with personalized bioinformatics tools. Cannabics' research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on the confluence of cutting edge technologies and personalized bioinformatic markers. |
